BioVacSafe - Biomarkers for enhanced vaccines immunosafety - is a 5 years project funded by Innovative Medicine initiative (IMI).
The goal of BioVacSafe is to develop cutting edge tools to speed up and improve the testing and monitoring of vaccine safety, both before and after release to the market. By bringing together for the first time three of Europe's leading vaccine development and manufacture companies as well as top experts from academic institutions and small and medium-sized enterprises (SMEs), the project will ultimately accelerate the development and introduction of a new generation of safer, more effective vaccines. By sharing their expertise, the BioVacSafe partners have a unique opportunity to make progress in this important area.
Project coordinator and Managing entity is the University of Surrey.
So far three studies have been conducted at Surrey CRC and one at University of Ghent. A further study has just been started at the Surrey CRC and another study is due to start soon at University of Ghent.
Surrey CTU is providing the project management and data management for this project.
- See more at: http://www.biovacsafe.eu